Key highlights

  • Australian Dairy Nutritionals (ASX:AHF) secured commitments for about AUD 1.54 million in an additional placement.
  • The subscription price was AUD 0.0173 for each new ordinary share.
  • The company earmarked proceeds for ongoing operations and working capital.

Australian Dairy Nutritionals (ASX:AHF) changed hands at AUD 0.017 on 20 November 2026, up 6.25% at 11:52 a.m. AEDT. The S&P/ASX 200 benchmark was in negative territory during the session. The integrated Victorian dairy and infant formula producer announced firm commitments for an additional AUD 1.54 million Placement on 30 October 2026.

Additional subscriptions add to October financing

On 30 October 2026, Australian Dairy Nutritionals announced firm commitments for 89,212,948 new fully paid ordinary shares at AUD 0.0173 each. Gross proceeds for the additional placement were AUD 1,543,384. The commitments came from new and existing sophisticated investors. The company had announced a separate strategic placement on 14 October, and the two placements together represented AUD 2,043,384 before costs. The additional shares were offered at the same price as the earlier placement. The October announcement treated the additional subscriptions as a financing step alongside the previously announced strategic investment.

Existing placement capacity and settlement

The company scheduled settlement and allotment of the additional shares for 6 November. It planned to issue them using available capacity under ASX Listing Rule 7.1, meaning completion did not require Shareholder approval. The new securities would rank equally with existing fully paid ordinary shares. Australian Dairy Nutritionals also planned to apply for Quotation of the new shares. The 30 October statement set out the scheduled mechanics for settlement and issue. Confirmation of actual allotment would be a distinct disclosure from the announcement of firm commitments and the planned timetable. The company intended the additional financing to strengthen its Balance Sheet while it implements its FY27 plan, and the share issue adds to the capital program announced earlier in October.

How the earlier placement was staged

The October update put the two placements at roughly AUD 2.04 million combined before costs, including AUD 500,000 from the earlier strategic placement. The company scheduled the AUD 200,000 second Tranche of the earlier placement for 30 October. It expected completion of the AUD 100,000 third tranche on or around 2 November. Those tranches have their own dates, separate from the planned 6 November allotment for the additional financing. The new commitments therefore increased the gross amount of an October financing program carried out through more than one subscription process.

Dairy production and working capital

Australian Dairy Nutritionals operates dairy farms and a processing Facility in southwestern Victoria. The company makes its Ocean Road Dairies organic A2 protein infant formula at its factory in Camperdown, using milk produced by its farms. That structure brings farm production and processing within the same group. The placement proceeds are allocated to ongoing operations and working capital. The announcement does not assign proceeds to particular farms, production runs or individual sales initiatives. It describes the funding at group level in the context of the board’s intention to strengthen the balance sheet as the FY27 plan progresses.

The transaction is reported before costs

Gross subscriptions describe the amount raised before any applicable issue costs. A subsequent cash balance also incorporates payments and receipts from operations. If the capital is allotted as described, the number of issued ordinary shares increases and the new holders participate on the same terms as other ordinary shareholders. Existing holders’ relative interests depend on the total number of shares they own after issue. The commitment announcement specifies the security count and subscription price. It leaves details about the rate and timing of Working Capital use to future financial reporting.

The next financing and operating measures

The documented dates for the earlier tranches and additional placement provide the timetable against which allotments can be recorded. Quarterly reporting can then place financing cash flows alongside expenditure and receipts from operations. The board’s stated purpose covers general working capital and ongoing costs through the FY27 planning period. Subsequent company reporting can provide greater detail on the relationship between cash balances, farm and processing activity and sales. The October disclosure concerns commitments, use of funds and issue terms. It does not set new production or Revenue guidance.

The October financing in brief

Australian Dairy Nutritionals arranged additional subscriptions at the earlier issue price. The two placements together represented just over AUD 2 million in gross financing.